The World of Health & Medicine News

Dinosaurs could hold key to cancer discoveries, scientists say

Dinosaurs could hold key to cancer discoveries, scientists say

Dinosaur fossils could hold the key to new cancer discoveries and influence future treatments for humans, scientists have said.

In a new study published in the journal Biology, which was almost a decade in the making, researchers from Anglia Ruskin University (ARU) and Imperial College London identified preserved red blood cell-like structures in a dinosaur fossil.

The findings raised the possibility that prehistoric creatures could be used to study ancient tumours, helping to fill in the “jigsaw” of cancer’s molecular building blocks, and potentially influencing future treatments for humans.

The idea for the study began when Professor Justin Stebbing, an oncologist at ARU, was reading the news in 2016 and came across an article about the discovery of a new fossil in Romania with a tumour in its jaw.

The remains were those of a Telmatosaurus transsylvanicus, a duck-billed, plant eating “marsh lizard”, a specimen that had lived between 66-70 million years ago in the Hateg Basin in present-day Romania.

“Justin said, guys, I want to go and get this tumour and see what we can get out of it,” Dr Biancastella Cereser, a cancer specialist at Imperial, told the PA news agency.

“We wanted to see if this tumour in the dinosaur could give us any information about any parallel with human cancers, because the tumour that this dinosaur had was an ameloblastoma, a benign tumour in the jaw, which humans have as well.”

From 2017, a team was put together, including three scientists who traditionally work on human cancers — Professor Stebbing, Dr Cereser, and Professor Pramodh Chandrasinghe from the University of Kelaniya in Sri Lanka.

“We contacted the town in Romania which was very excited to loan us the fossil,” Dr Cereser said.

“We went to Romania and collected the specimen. We brought it back, and we basically drilled into it with a very, very, very fine drill.

“Then we mounted it into this very sophisticated microscope and imaged it. What we saw inside – there were some structures, some forms, that looked like blood cells.”

This Scanning Electron Microscopy (SEM) technique enabled the researchers to identify low-density structures resembling erythrocytes, or red blood cells, in the fossilised bone.

“Up until recently, the fossil record and finding ancient things was really interesting for finding hard things like shells or skeletons to assess tissues,” Professor Stebbing said.

“But if we’re trying to look at the building blocks of life or the building blocks of cancer, to understand cancer better, what we found was you can actually as well as seeing the skeleton we can actually see soft tissue as well.

spot_img

Explore more

spot_img

Scientists Discover Promising New Alzheimer’s Treatment

Scientists Discover Promising New Alzheimer’s Treatment Researchers at Case Western Reserve University have developed a drug that protects the “guardian of the brain.” More than 55...

Harvard seeks end to US funding cuts, says national security, public...

Harvard seeks end to US funding cuts, says national security, public health research in peril  Harvard University asked a federal judge on Monday to issue...

Gilead’s CAR-T cell therapy shows promise in deadly brain cancer

Gilead's CAR-T cell therapy shows promise in deadly brain cancer A Gilead Sciences-backed therapy made with a patient's own white blood cells shrank tumors in...

Bird Flu Is Now Killing Cats at a 90% Fatality Rate...

Bird Flu Is Now Killing Cats at a 90% Fatality Rate – Experts Warn It Could Jump to Humans Spring is here, birds are on...

Amgen drug cuts small cell lung cancer death risk by 40%

Amgen drug cuts small cell lung cancer death risk by 40% Amgen's (AMGN.O), opens new tab Imdelltra reduced the risk of death by 40% compared to chemotherapy...

Bristol Myers to pay $1.5 billion upfront for BioNTech cancer drug...

Bristol Myers to pay $1.5 billion upfront for BioNTech cancer drug partnership Bristol Myers Squibb (BMY.N), opens new tab will pay $1.5 billion upfront to partner with...

US FDA approves Moderna’s next-generation COVID vaccine for adults 65 or...

US FDA approves Moderna's next-generation COVID vaccine for adults 65 or older The U.S. Food and Drug Administration has approved Moderna's (MRNA.O), opens new tab next-generation COVID-19...

Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer...

Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds Treating breast cancer patients with AstraZeneca's (AZN.L), opens new tab experimental pill camizestrant...